%0 Journal Article
%T A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
%A Peter Lommer Kristensen
%A UIrik Pedersen-Bjergaard
%A Henning Beck-Nielsen
%A Kirsten N£¿rgaard
%A Hans Perrild
%A Jens Sandahl Christiansen
%A Tonny Jensen
%A Hans-Henrik Parving
%A Birger Thorsteinsson
%A Lise Tarnow
%J BMC Endocrine Disorders
%D 2012
%I BioMed Central
%R 10.1186/1472-6823-12-10
%X The study is a Danish two-year investigator-initiated, prospective, randomised, open, blinded endpoint (PROBE), multicentre, cross-over trial investigating the effect of insulin analogues versus human insulin on the frequency of severe hypoglycaemia in subjects with type 1 diabetes. Patients are randomised to treatment with basal-bolus therapy with insulin detemir / insulin aspart or human NPH insulin / human regular insulin in random order. The major inclusion criterion is history of two or more episodes of severe hypoglycaemia in the preceding year.In contrast to almost all other studies in this field the HypoAna Trial includes only patients with major problems with hypoglycaemia. The HypoAna Trial will elucidate whether basal-bolus regimen with short-acting and long-acting insulin analogues in comparison with human insulin are superior in reducing occurrence of severe hypoglycaemic episodes in hypoglycaemia prone patients with type 1 diabetes. http://www.clinicaltrials.gov webcite: NCT00346996.
%K Type 1 diabetes
%K Severe hypoglycaemia
%K Human insulin
%K Insulin analogues
%K PROBE
%U http://www.biomedcentral.com/1472-6823/12/10/abstract